Bedaquiline Resistance after Effective Treatment of Multidrug-Resistant Tuberculosis, Namibia

Bedaquiline is currently a key drug for treating multidrug-resistant or rifampin-resistant tuberculosis. We report and discuss the unusual development of resistance to bedaquiline in a teenager in Namibia, despite an optimal background regimen and adherence. The report highlights the risk for bedaq...

Πλήρης περιγραφή

Λεπτομέρειες βιβλιογραφικής εγγραφής

Κύριοι συγγραφείς:	Gunar Günther, Lusia Mhuulu, Azaria Diergaardt, Viola Dreyer, Maria Moses, Kaarna Anyolo, Nunurai Ruswa, Mareli Claassens, Stefan Niemann, Emmanuel Nepolo
Μορφή:	Artigo
Γλώσσα:	Inglês
Έκδοση:	Centers for Disease Control and Prevention 2024-03-01
Σειρά:	Emerging Infectious Diseases
Θέματα:	tuberculosis TB tuberculosis and other mycobacteria bacteria respiratory infections bedaquiline
Διαθέσιμο Online:	https://wwwnc.cdc.gov/eid/article/30/3/24-0134_article
Ετικέτες:	Προσθήκη ετικέτας Δεν υπάρχουν, Καταχωρήστε ετικέτα πρώτοι!